Related Experiment Video

Updated: May 11, 2026

Retinal Pathophysiological Evaluation in a Rat Model
09:11

Retinal Pathophysiological Evaluation in a Rat Model

Published on: May 6, 2022

Evaluation of antioxidant efficacy of vanadium-3-hydroxyflavone complex in streptozotocin-diabetic rats

Subramanian Iyyam Pillai1, Sorimuthu Pillai Subramanian, Muthusamy Kandaswamy

  • 1Department of Inorganic Chemistry, School of Chemical Science, University of Madras, Guindy Campus, Chennai 600 025, India.

Chemico-Biological Interactions
|May 14, 2013
PubMed

Insights

A novel vanadium complex (V3HF) combats diabetes by improving pancreatic beta cell function and reducing oxidative stress in diabetic rats. This approach aims to mitigate vanadium toxicity while enhancing its therapeutic potential for diabetes management.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Toxicology

Background:

  • Vanadium compounds show antidiabetic potential, but toxicity concerns limit their use.
  • Hyperglycemia-induced oxidative stress is a key factor in diabetes complications.
  • Novel vanadium complexes are needed to improve efficacy and reduce toxicity.

Purpose of the Study:

  • To synthesize and characterize a novel vanadium complex (V3HF).
  • To evaluate the antidiabetic and toxicological potential of V3HF in streptozotocin (STZ)-induced diabetic rats.
  • To investigate the effect of V3HF on hyperglycemia-mediated oxidative stress and pancreatic beta cell function.

Main Methods:

  • Synthesis and characterization of the V3HF complex.
  • Induction of diabetes in rats using streptozotocin (STZ).
  • Administration of V3HF to diabetic rats and assessment of glycemic control, oxidative stress markers, and pancreatic beta cell function via histological and ultrastructural studies.

Main Results:

  • The V3HF complex demonstrated antidiabetic effects in STZ-diabetic rats.
  • V3HF treatment improved pancreatic beta cell function.
  • Histological and ultrastructural analyses confirmed that V3HF protects beta cells from hyperglycemia-induced oxidative stress.

Conclusions:

  • The novel V3HF complex shows promise as an antidiabetic agent with a reduced toxicity profile.
  • V3HF effectively mitigates hyperglycemia-mediated oxidative stress, preserving pancreatic beta cell integrity.
  • This vanadium complex warrants further investigation for its therapeutic application in managing diabetes.

More Related Videos

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats07:41

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Published on: October 23, 2020

An Ultrasonic Tool for Nerve Conduction Block in Diabetic Rat Models10:27

An Ultrasonic Tool for Nerve Conduction Block in Diabetic Rat Models

Published on: October 20, 2017

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...